Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans

Sid E O'Bryant1, Melissa Petersen1,2, James Hall1

  • 1Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, United States.

Frontiers in Psychiatry
|September 9, 2022
PubMed
Abstract

Insights

Depressive symptoms impact cognitive and Alzheimer's disease (AD) biomarkers differently in Mexican Americans compared to non-Hispanic whites. These symptoms are more strongly linked to AD outcomes in Mexican American non-carriers of the APOEε4 gene variant.

Area of Science:

  • Neuroscience
  • Gerontology
  • Public Health

Background:

  • Alzheimer's disease (AD) research significantly underrepresents Mexican Americans, a key demographic within the US Hispanic community.
  • Existing data suggest distinct AD risk factors and biomarkers in Mexican Americans compared to non-Hispanic whites.
  • Understanding ethnic-specific variations in AD is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the influence of depressive symptoms on cognitive function and AD-related biomarkers in Mexican Americans.
  • To compare these associations between Mexican Americans and non-Hispanic whites.
  • To identify potential ethnic-specific patterns in AD pathology.

Main Methods:

  • Analysis of data from 1,633 participants (852 Mexican Americans, 781 non-Hispanic whites) in the Health and Aging Brain Study-Health Disparities (HABS-HD).
  • Assessment of depressive symptoms using the Geriatric Depression Scale.
  • Measurement of cognitive function via neuropsychological testing, plasma biomarkers (Aβ40, Aβ42, tau, NfL), and neuroimaging (MRI, PET amyloid).

Main Results:

  • Depressive symptoms showed significant associations with cognitive test results in both Mexican Americans and non-Hispanic whites.
  • In Mexican Americans, depression was significantly linked to cognitive outcomes and plasma biomarkers only among individuals who were not carriers of the APOEε4 gene variant.
  • These findings highlight a differential impact of depression on AD-related markers within this ethnic group.

Conclusions:

  • Depressive symptoms are more prevalent and more strongly associated with cognitive and AD biomarker outcomes in Mexican Americans.
  • The association between depression and AD outcomes is specifically observed in Mexican American non-carriers of the APOEε4 gene.
  • These results support the development of precision medicine approaches tailored to the unique needs of the Mexican American population for cognitive health.

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
326
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
157
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
115
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
202
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
234
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K